[EN] DEGRADERS OF WILD-TYPE AND MUTANT FORMS OF LRRK2<br/>[FR] AGENTS DE DÉGRADATION DE FORMES DE TYPE SAUVAGE ET MUTANTES DE LA KINASE LRRK2
申请人:DANA FARBER CANCER INST INC
公开号:WO2020081682A1
公开(公告)日:2020-04-23
Disclosed are bifunctional compounds (degraders) that target LRKK2 for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the degraders to treat neurodegenerative diseases and disorders such as Parkinson's disease and brain cancer (e.g., gliomas and glioblastomas).